(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENOPREDICTA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GENOPREDICTA

ST13

US500000099232771

Class

5, 10, 42, 44

Filing

99232771

Registration

8249759

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

05/12/2026

Trademark type

Word

Nice classes

5, 10, 42, 44

Filing date

06/13/2025

Registration date

05/12/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/12/2026

Last transaction

05/12/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

03/01/2024

First use in commerce

04/29/2025

Drawing code

4

Owner type

03

Owner location

Cambridge, MA, US

Examiner

CLONCH, ABIGAIL

Law office

M50

Current location

TMO LAW OFFICE 114

Holders and representatives

Holders

Predicta Biosciences, Inc.

Representatives

M Grace Worley Startlaw PC

Technical classification

Nice Classes

Class 5Class 10Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic preparations for use in assessment of genomic analysis for medical use; Biological preparations for use in cell cultures for medical purposes; Diagnostic preparations for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectiongenomic testing for multiple myeloma diagnosisprognosistherapeutic management

Class 10

Genetic testing apparatus for medical purposes; Apparatus for DNA and RNA testing for medical purposes; Medical apparatus and instrument for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing

Class 42

Scientific laboratory services in the field of genomics; Research and development services in the field of genomics; Biochemical research and development; Medical and scientific research in the field of cancer treatment and diagnosis; Genetic mapping for scientific purposes

Class 44

Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis for the diagnosis and treatment of persons; Medical analysis services for the diagnosis of cancer; Medical testing services relating to the diagnosis and treatment of disease; Providing information in the field of cancer preventionscreeningdiagnosis and treatment; Genetic testing for medical purposes

Publications

History of USPTO decisions and trademark events.

16 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/12/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

05/12/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/24/2026

PUBO

PUBLISHED FOR OPPOSITION

03/24/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/18/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/26/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/30/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/30/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/30/2026

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/06/2025

GNRT

NON-FINAL ACTION E-MAILED

11/06/2025

CNRT

NON-FINAL ACTION WRITTEN

11/06/2025

DOCK

ASSIGNED TO EXAMINER

11/03/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/15/2025

MAFR

APPLICATION FILING RECEIPT MAILED

06/13/2025

NWAP

NEW APPLICATION ENTERED

06/13/2025

Continuous trademark protection

Get notified about every new filing that threatens GENOPREDICTA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.